BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9882102)

  • 1. Deletions in the long arm of chromosome 10 in lymphomas with t(14;18): a pathogenetic role of the tumor supressor genes PTEN/MMAC1 and MXI1?
    Siebert R; Gesk S; Harder S; Plötz S; Matthiesen P; Grote W; Schlegelberger B; Jandrig B; Grasmo-Wendler UH; Scherneck S; Rosenwald A; Ott G
    Blood; 1998 Dec; 92(11):4487-9. PubMed ID: 9882102
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of deletions of the PTEN/MMAC1 and MXI1 loci in renal cell carcinoma by interphase cytogenetics.
    Gesk S; Siebert R; Wacker HH; Nürnberg N; Harder L; Lehman J; Klöppel G; Grote W; Stöckle M; Schlegelberger B
    Cancer Genet Cytogenet; 2000 Apr; 118(1):87-8. PubMed ID: 10766523
    [No Abstract]   [Full Text] [Related]  

  • 3. Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme.
    Fults D; Pedone CA; Thompson GE; Uchiyama CM; Gumpper KL; Iliev D; Vinson VL; Tavtigian SV; Perry WL
    Int J Oncol; 1998 Apr; 12(4):905-10. PubMed ID: 9499454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN and MXI1 allelic loss on chromosome 10q is rare in melanoma in vivo.
    Herbst RA; Podewski EK; Mommert S; Kapp A; Weiss J
    Arch Dermatol Res; 1999 Oct; 291(10):567-9. PubMed ID: 10552217
    [No Abstract]   [Full Text] [Related]  

  • 5. Partial trisomy 10q with mild phenotype caused by an unbalanced X;10 translocation.
    Mononen T; Sharp A; Laakso M; Meltoranta RL; Valve-Dietz AK; Heinonen K
    J Med Genet; 2003 May; 40(5):e61. PubMed ID: 12746415
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular analysis of PTEN and MXI1 in primary bladder carcinoma.
    Wang DS; Rieger-Christ K; Latini JM; Moinzadeh A; Stoffel J; Pezza JA; Saini K; Libertino JA; Summerhayes IC
    Int J Cancer; 2000 Nov; 88(4):620-5. PubMed ID: 11058880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.
    Kuczyk MA; Serth J; Bokemeyer C; Schwede J; Herrmann R; Machtens S; Grünewald V; Höfner K; Jonas U
    Oncol Rep; 1998; 5(1):213-6. PubMed ID: 9458379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN gene alterations in lymphoid neoplasms.
    Sakai A; Thieblemont C; Wellmann A; Jaffe ES; Raffeld M
    Blood; 1998 Nov; 92(9):3410-5. PubMed ID: 9787181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic losses and genetic instabilities of PTEN and p73 in non-Hodgkin lymphomas.
    Herranz M; Urioste M; Santos J; Martinez-Delgado JB; Rivas C; Benitez J; Fernández-Piqueras J
    Leukemia; 2000 Jul; 14(7):1325-7. PubMed ID: 10914564
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.
    Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS
    Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10.
    Poetsch M; Lorenz G; Kleist B
    Cancer Genet Cytogenet; 2002 Jan; 132(1):20-4. PubMed ID: 11801303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma.
    Yeh KT; Chang JG; Chen YJ; Chen ST; Yu SY; Shih MC; Perng LI; Wang JC; Tsai M; Chang CP
    Cancer Invest; 2000; 18(2):123-9. PubMed ID: 10705874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the MMAC1/PTEN gene in lymphoid malignancies.
    Grønbaek K; Zeuthen J; Guldberg P; Ralfkiaer E; Hou-Jensen K
    Blood; 1998 Jun; 91(11):4388-90. PubMed ID: 9596690
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin's lymphoma.
    Nakahara Y; Nagai H; Kinoshita T; Uchida T; Hatano S; Murate T; Saito H
    Leukemia; 1998 Aug; 12(8):1277-80. PubMed ID: 9697884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity.
    Mavros A; Hahn M; Wieland I; Koy S; Koufaki ON; Strelocke K; Koch R; Haroske G; Schackert HK; Eckelt U
    J Oral Pathol Med; 2002 May; 31(5):270-6. PubMed ID: 12110043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
    Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
    Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas.
    Liu W; James CD; Frederick L; Alderete BE; Jenkins RB
    Cancer Res; 1997 Dec; 57(23):5254-7. PubMed ID: 9393744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
    Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
    Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of PTEN mutations and deletions in B-cell non-Hodgkin's lymphomas.
    Butler MP; Wang SI; Chaganti RS; Parsons R; Dalla-Favera R
    Genes Chromosomes Cancer; 1999 Apr; 24(4):322-7. PubMed ID: 10092130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of PTEN/MMAC1 alteration in neuroblastoma.
    Moritake H; Horii Y; Kuroda H; Sugimoto T
    Cancer Genet Cytogenet; 2001 Mar; 125(2):151-5. PubMed ID: 11369059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.